Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 28% ± 7% | |
GABAergic neuron | 3 studies | 27% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 5470.11 | 2555 / 2642 | 87% | 13.22 | 614 / 705 |
pancreas | 100% | 67287.23 | 328 / 328 | 66% | 72.82 | 118 / 178 |
stomach | 80% | 7538.35 | 288 / 359 | 49% | 6.86 | 139 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.40 | 1 / 1 |
intestine | 39% | 220.40 | 372 / 966 | 45% | 6.48 | 238 / 527 |
ovary | 3% | 21.62 | 6 / 180 | 41% | 5.16 | 177 / 430 |
adrenal gland | 2% | 21.55 | 4 / 258 | 41% | 3.34 | 94 / 230 |
prostate | 4% | 16.07 | 11 / 245 | 36% | 5.68 | 183 / 502 |
esophagus | 8% | 43.95 | 122 / 1445 | 25% | 6.03 | 46 / 183 |
lung | 1% | 4.78 | 7 / 578 | 26% | 7.15 | 301 / 1155 |
uterus | 0% | 0 | 0 / 170 | 25% | 2.54 | 115 / 459 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.92 | 7 / 29 |
heart | 22% | 98.84 | 193 / 861 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 20% | 2.00 | 101 / 504 |
liver | 0% | 1.36 | 1 / 226 | 18% | 4.22 | 73 / 406 |
eye | 0% | 0 | 0 / 0 | 14% | 0.58 | 11 / 80 |
skin | 0% | 2.30 | 3 / 1809 | 13% | 3.05 | 62 / 472 |
adipose | 11% | 70.47 | 129 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.10 | 4 / 45 |
breast | 3% | 13.53 | 12 / 459 | 5% | 1.09 | 60 / 1118 |
kidney | 4% | 17.04 | 4 / 89 | 3% | 0.62 | 24 / 901 |
thymus | 0% | 1.68 | 3 / 653 | 1% | 0.19 | 9 / 605 |
blood vessel | 2% | 13.24 | 22 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.56 | 3 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.37 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0006621 | Biological process | protein retention in ER lumen |
GO_0034975 | Biological process | protein folding in endoplasmic reticulum |
GO_0070527 | Biological process | platelet aggregation |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0015036 | Molecular function | disulfide oxidoreductase activity |
GO_0015035 | Molecular function | protein-disulfide reductase activity |
GO_0003756 | Molecular function | protein disulfide isomerase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005496 | Molecular function | steroid binding |
Gene name | PDIA2 |
Protein name | Protein disulfide isomerase family A member 2 protein disulfide-isomerase (EC 5.3.4.1) Protein disulfide isomerase family A, member 2 Protein disulfide-isomerase A2 (EC 5.3.4.1) (Pancreas-specific protein disulfide isomerase) (PDIp) Protein disulfide isomerase family A member 2 (Protein disulfide isomerase family A, member 2) |
Synonyms | LA16c-314G4.2-005 PDIP LA16c-314G4.2-007 |
Description | FUNCTION: Acts as an intracellular estrogen-binding protein. May be involved in modulating cellular levels and biological functions of estrogens in the pancreas. May act as a chaperone that inhibits aggregation of misfolded proteins. . |
Accessions | ENST00000456379.1 H0Y4J5 ENST00000219406.11 [Q13087-1] ENST00000435833.1 A4L733 Q4TT66 ENST00000404312.5 [Q13087-2] Q13087 Q4TT65 |